Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer
Bastiaan M. Privé, Peter H. J. Slootbeek, Babette I. Laarhuis, Samhita Pamidimarri Naga, Maarten J. van der Doelen, Ludwike W. M. van Kalmthout, Bart de Keizer, Samer Ezziddin, Clemens Kratochwil, Aliyah Morgenstern, Frank Bruchertseifer, Marjolijn J. L. Ligtenberg, J. Alfred Witjes, Inge M. van Oort, Martin Gotthardt, Sandra Heskamp, Marcel J. R. Janssen, Winald R. Gerritsen, James Nagarajah, Niven Mehra
Topics & Concepts
MedicineProstate cancerRadioligandOncologyCastrationInternal medicineBenign prostatic hyperplasia (BPH)Cancer researchCancerUrologyReceptorHormoneProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentRadiopharmaceutical Chemistry and Applications